Danaher

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Danaher 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About DHR

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. 

CEO
Rainer M. Blair
CEORainer M. Blair
Employees
60,000
Employees60,000
Headquarters
Washington, District of Columbia
HeadquartersWashington, District of Columbia
Founded
1984
Founded1984
Employees
60,000
Employees60,000

DHR Key Statistics

Market cap
148.94B
Market cap148.94B
Price-Earnings ratio
41.48
Price-Earnings ratio41.48
Dividend yield
0.61%
Dividend yield0.61%
Average volume
4.43M
Average volume4.43M
High today
$210.64
High today$210.64
Low today
$206.88
Low today$206.88
Open price
$207.61
Open price$207.61
Volume
5.24M
Volume5.24M
52 Week high
$242.80
52 Week high$242.80
52 Week low
$171.00
52 Week low$171.00

Stock Snapshot

Danaher(DHR) stock is priced at $210.64, giving the company a market capitalization of 148.94B. It carries a P/E multiple of 41.48 and pays a dividend yield of 61.1%.

On 2026-02-27, Danaher(DHR) stock moved within a range of $206.88 to $210.64. With shares now at $210.64, the stock is trading +1.8% above its intraday low and 0.0% below the session's peak.

Trading activity shows a volume of 5.24M, compared to an average daily volume of 4.43M.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $171.00.

Over the past 52 weeks, Danaher(DHR) stock has traded between a high of $242.80 and a low of $171.00.

DHR News

Simply Wall St 56m
Danaher’s US$9.9b Masimo Deal Refocuses Growth On Diagnostics Valuation

Danaher (NYSE:DHR) has agreed to acquire Masimo Corporation in a cash and stock deal valued at $9.9b. Masimo, a specialty diagnostics leader, will operate as a...

Danaher’s US$9.9b Masimo Deal Refocuses Growth On Diagnostics Valuation
Simply Wall St 1d
Assessing Danaher Valuation After Recent Share Price Weakness

Advertisement Why Danaher stock may be on your radar today Danaher (DHR) has been drawing attention after recent share price moves, with the stock around $209...

Assessing Danaher Valuation After Recent Share Price Weakness
Simply Wall St 4d
Danaher Masimo Deal Reshapes Patient Monitoring And Diagnostics Exposure

Danaher (NYSE:DHR) has entered a definitive agreement to acquire health tech firm Masimo. The deal will bring Masimo into Danaher as a standalone operating uni...

Danaher Masimo Deal Reshapes Patient Monitoring And Diagnostics Exposure

Analyst ratings

85%

of 27 ratings
Buy
85.2%
Hold
14.8%
Sell
0%

People also own

Based on the portfolios of people who own DHR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.